Correlation between interleukin 35 or interleukin 37 and clinicopathology and prognosis of colorectal cancer

陈飞儿; 张　凤; 谈振宇; 夏庆华; 包士三; 陶　琨; 董志恒

doi:10.19401/j.cnki.1007-3639.2020.06.008

您当前的位置：

首页 >

文章列表页 >

Correlation between interleukin 35 or interleukin 37 and clinicopathology and prognosis of colorectal cancer

更新时间：2026-01-27

- Correlation between interleukin 35 or interleukin 37 and clinicopathology and prognosis of colorectal cancer
- China Oncology Vol. 30, Issue 6, Pages: 456-461(2020)
- 作者机构：
  
  1. 北华大学医学院病理教研室,吉林,吉林,132000
  2. 上海交通大学医学院附属同仁医院病理科,上海,200336
  3. 上海市长宁区疾病预防控制中心,上海,200050
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2020.06.008
  CLC： R735.34
- Published Online：16 July 2020，
  
  Published：16 July 2020
- 稿件说明：
移动端阅览
陈飞儿 , 张　凤 , 谈振宇 , 夏庆华 , 包士三 , 陶　琨 , 董志恒 . 白细胞介素35和白细胞介素37与结直肠癌临床病理学特征及预后的相关性研究[J]. 中国癌症杂志, 2020, 30(6): 456-461.

陈飞儿, 张　凤, 谈振宇, et al. Correlation between interleukin 35 or interleukin 37 and clinicopathology and prognosis of colorectal cancer[J]. China Oncology, 2020, 30(6): 456-461.
陈飞儿 , 张　凤 , 谈振宇 , 夏庆华 , 包士三 , 陶　琨 , 董志恒 . 白细胞介素35和白细胞介素37与结直肠癌临床病理学特征及预后的相关性研究[J]. 中国癌症杂志, 2020, 30(6): 456-461. DOI： 10.19401/j.cnki.1007-3639.2020.06.008.

陈飞儿, 张　凤, 谈振宇, et al. Correlation between interleukin 35 or interleukin 37 and clinicopathology and prognosis of colorectal cancer[J]. China Oncology, 2020, 30(6): 456-461. DOI： 10.19401/j.cnki.1007-3639.2020.06.008.

摘要

背景与目的：结直肠癌（colorectal cancer，CRC）为世界第三常见恶性肿瘤，近年来研究者认为白细胞介素（interleukin，IL）-35和（或）IL-37与CRC的发展有关，但其作用机制尚未阐明。探究IL-35和IL-37在CRC发展中的作用及其可能的机制，分析IL-35和IL-37与CRC患者预后的相关性。方法：收集2013年—2017年在上海交通大学医学院附属同仁医院接受治疗的191例CRC患者手术病理蜡块的肿瘤组织，与其匹配的非癌组织是来源于同一患者的肠癌手术切缘蜡块组织。应用免疫组织化学（immunohistochemistry，IHC）染色法将CRC患者的癌组织与非癌组织染色，并运用Image-Pro Plus将IHC染色阳性部分定量分析，结合随访结果，探讨癌组织与非癌组织中IL-35和IL-37的表达水平与CRC临床病理学特征及预后的相关性。结果：与非癌组织相比，CRC组织中IL-35的表达量减少了50%（P0.000 1）。CRC组织中IL-37的表达量与非癌组织相比增加了40%（P=0.012）。多因素生存分析显示，癌组织中IL-35（HR=0.39；95% CI：0.16~0.97；P=0.04）的表达水平是CRC患者术后生存的独立预测指标。结论：IL-35和IL-37蛋白的表达水平可能与CRC的发展有关，IL-35的表达水平可能是CRC患者术后生存的独立预测指标。

Abstract

Background and purpose: Colorectal cancer (CRC) is the third most common cancer in the world. Recently

it is suggested that interleukin (IL)-35 and/or IL-37 are associated with CRC

but the precise underlying mechanism has not been fully explored. The aim of this study was to explore the correlation between IL-35 or IL-37 and clinicopathology of CRC

and to determine whether IL-35 or IL-37 could be used as prognosis biomarker for CRC patients. Methods: Tissue array was generated from both CRC (n=191) and the matched non-cancer tissues (n=141) from the same patient’s adjacent tissues from 2013 to 2017 in Department of Pathology

Tongren Hospital

Shanghai Jiao Tong University School of Medicine. Quantitative analysis for IL-35 and IL-37 was performed on these immunohistochemically (IHC) labelled tissues using Image-Pro Plus software

for comparison between cancer and non-cancer tissues. We investigated the correlation between IL-35/IL-37 in the CRC tissues and pathology

as well as prognosis. Results: The expression of IL-35 was decreased by 50% in CRC tissues compared with non-cancer tissues (P0.000 1). In contrast

the expression of IL-37 was increased by 40% in CRC tissues compared with non-cancer tissues (P=0.012). Furthermore

the expression of IL-35

but not IL-37

in cancer tissues (HR=0.39

95% CI: 0.16-0.97

P=0.04) was an independent predictor of postoperative survival in CRC patients

using the multivariate survival analysis. Conclusion: The expression of IL-35 or IL-37 may be involved in the development of CRC. The expression of IL-35 is believed to be an independent predictor of postoperative survival in CRC patients. The precise mechanism of IL-35 and IL-37 in the development of CRC in vivo will be determined in future.

关键词

Keywords

references

Views

2352

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Impact of MSI-H/dMMR on clinicopathological characteristics and prognosis of patients with BRAF V600E-mutated resectable colorectal cancer

Exploring the prognostic value of positive lymph node ratio in stage Ⅲ colorectal cancer patients and establishing a predictive model

Correlation study between advanced age and inferior prognosis in stage Ⅱ colorectal cancer patients

The clinical value of mismatch repair protein combined with serum tumor markers and Ki-67 proliferation index in the prognostic evaluation of colorectal cancer

Prognostic value of inflammatory and immune markers in resectable colorectal cancer

Related Author

Jun LI

Tingwei LU

Xuqian FANG

Wen WU

Ruoxin ZHANG

Junyong WENG

Yanlei MA

Guoxiang CAI

Related Institution

Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

Department of Colorectal Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

Department of Oncology, Huadong Hospital Affiliated to Fudan University

AI问答

⁰